deflazacort

Generic: deflazacort

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deflazacort
Generic Name deflazacort
Labeler aurobindo pharma limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

deflazacort 36 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 59651-602
Product ID 59651-602_dc2886e0-4e19-4a7c-b7ae-5723d7b4b8c9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217123
Listing Expiration 2026-12-31
Marketing Start 2024-02-09

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59651602
Hyphenated Format 59651-602

Supplemental Identifiers

RxCUI
153098 153880 1870954 1870958
UPC
0359651600306
UNII
KR5YZ6AE4B
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deflazacort (source: ndc)
Generic Name deflazacort (source: ndc)
Application Number ANDA217123 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 36 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (59651-602-30)
source: ndc

Packages (1)

59651-602-30 30 TABLET in 1 BOTTLE (59651-602-30)

Ingredients (1)

deflazacort (36 mg/1)

Linked Drug Pages (1)

Deflazacort ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "dc2886e0-4e19-4a7c-b7ae-5723d7b4b8c9", "openfda": {"nui": ["N0000175576", "N0000175450"], "upc": ["0359651600306"], "unii": ["KR5YZ6AE4B"], "rxcui": ["153098", "153880", "1870954", "1870958"], "spl_set_id": ["77d7525d-89c9-4fde-a6a8-0a463fd6cfeb"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (59651-602-30)", "package_ndc": "59651-602-30", "marketing_start_date": "20240209"}], "brand_name": "Deflazacort", "product_id": "59651-602_dc2886e0-4e19-4a7c-b7ae-5723d7b4b8c9", "dosage_form": "TABLET", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "59651-602", "generic_name": "Deflazacort", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deflazacort", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "36 mg/1"}], "application_number": "ANDA217123", "marketing_category": "ANDA", "marketing_start_date": "20240209", "listing_expiration_date": "20261231"}